Phase 2/3 Study of EUS-guided Ethanol Lavage With Paclitaxel Injection for Cystic Tumors of the Pancreas
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Incidence of complications Treatment response by change of calculated cyst volume
30-days for complication and at least 6 months for treatment response
Yes
Dong Wan Seo, M.D., Ph.D
Principal Investigator
Asan Medical Center, University of Ulsan Collge of Medicine
Korea: Food and Drug Administration
AMC0183
NCT00689715
June 2006
February 2012
Name | Location |
---|